miR-130 aggravates acute myocardial infarction-induced myocardial injury by targeting PPAR-γ

Xianglin Chu1, Yiqing Wang1, Liewen Pang1

  • 1Department of Cardiothoracic Surgery, Huashan Hospital, Fudan University, Shanghai, China.

Insights

Downregulating miR-130 alleviates myocardial injury after infarction by increasing peroxisome proliferator-activated receptor γ (PPAR-γ) expression. This reduces inflammation and fibrosis, offering a potential therapeutic strategy for acute myocardial infarction (AMI).

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • MicroRNA Therapeutics

Background:

  • Cardiac remodeling is a key pathological change following acute myocardial infarction (AMI).
  • MicroRNAs are critical posttranscriptional regulators influencing myocardial tissue post-AMI.
  • The specific role of miR-130 in AMI pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role and mechanism of miR-130 in acute myocardial infarction (AMI).
  • To explore the potential of targeting miR-130 for therapeutic intervention in myocardial injury.

Main Methods:

  • Utilized H9c2 cells under hypoxia to simulate myocardial infarction.
  • Employed RT-PCR, Western blot, and ELISA to assess miR-130's effects.
  • Verified miR-130 targets using bioinformatics and luciferase reporter assays.
  • Confirmed findings in a rat model of induced myocardial injury.

Main Results:

  • miR-130 downregulation reduced hypoxia-induced inflammation and fibrosis in H9c2 cells.
  • miR-130 inhibition reversed hypoxia-induced suppression of peroxisome proliferator-activated receptor γ (PPAR-γ).
  • PPAR-γ was confirmed as a direct target of miR-130, mediating cardioprotection by inhibiting NFκB and TGF-β1.
  • In vivo studies showed miR-130 knockdown enhanced PPAR-γ's protective effects against myocardial injury.

Conclusions:

  • miR-130 knockdown alleviates infarction-induced myocardial injury.
  • The mechanism involves promoting PPAR-γ expression, which suppresses inflammation and fibrosis.
  • Targeting miR-130 represents a promising therapeutic strategy for acute myocardial infarction.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
797
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
489
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
365
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
979
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
346